Local News
Local News

Dunwoody candidates forum on environment and development

By Ty Tagami
Oct 7, 2011

Candidates for Dunwoody city council and the mayor's office will lay out their positions on the environment and development at public forum.

The Oct. 25 event, sponsored by the Dunwoody Student Volunteer Organization and League of Women Voters, is from 6 p.m. to 9 p.m. at Peachtree Charter Middle School, 4664 N. Peachtree Rd., said organizer Joe Seconder.

Topics include: "green" technology, business practices, park and trail planning, transportation, energy, trash, local food production, air and water quality and a "sustainability plan" for the city.

About the Author

Ty Tagami is a staff writer for The Atlanta Journal-Constitution. Since joining the newspaper in 2002, he has written about everything from hurricanes to homelessness. He has deep experience covering local government and education, and can often be found under the Gold Dome when lawmakers meet or in a school somewhere in the state.

Follow Ty Tagami on facebookFollow Ty Tagami on twitter
More Stories

The Latest

Jeffrey Briney was convicted of rape in two sexual assault cases that took place in 1986 in DeKalb County. (Dreamstime/TNS)

Credit: TNS

DNA leads to conviction of man in decades-old DeKalb sexual assaults

Student injured in lab explosion at Georgia Tech

Ex-Georgia poll worker to serve 20 months for threatening to bomb precinct

Featured

(Photo Illustration: Philip Robibero / AJC | Source: File, Pexels)

Credit: Philip Robibero / AJC

EXCLUSIVE

Amid federal pressure, Atlanta forced to evaluate vaunted contract diversity goals

The prospect of losing programs that require certain minority and women-owned business participation is "one of the most consequential moments in our history," the mayor said.

Time is running out to cash in on federal EV, clean energy tax credits

The clock is ticking for Georgians to use federal EV and clean energy tax credits to save money on a range of projects.

A rare disease exhausted him. A drug gives him energy to fight for others.

An FDA review of a drug for Barth syndrome shines a spotlight on how the agency weighs experimental treatments for rare diseases, which affect almost 30 million Americans.